Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow Inc. experienced significant growth, with approximately 48% worldwide FFR-CT volume growth translating into a notable revenue increase of 41% year-over-year, reaching $46.3 million in 3Q25. The company's gross margins improved to 76.8%, reflecting operational efficiency and strong demand for its FFR-CT coronary disease analysis software, while management highlights continued growth in coronary CT angiography adoption and new account acquisitions. Looking forward, HeartFlow is poised for sustainable revenue growth in the mid-20% range, driven by the expansion of its core business and potential future contributions from plaque analysis revenues.

Bears say

HeartFlow Inc. faces a significant negative outlook due to its ongoing pattern of substantial net losses, totaling $95.7 million in FY23 and $96.4 million in FY24, with expectations of continued losses in the foreseeable future. Additionally, the company relies heavily on healthcare providers adhering to specific guidelines for the utilization of its technology, raising concerns about the widespread adoption of its HeartFlow platform. Compounding these issues is the reimbursement risk; if third-party payors do not adequately cover the HeartFlow platform, or if changes further limit reimbursement, the company's financial stability and growth potential may be severely jeopardized.

HeartFlow Inc (HTFL) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 5 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.